PEARL Annual Meeting
Event archive: October 2023
The Pediatric Endocrine Association for Research and Learning (PEARL) 2023 Annual Meeting is a two-day educational conference featuring topics on diabetes, endocrine pathophysiology and patient care. Experience the vibrant atmosphere of our pediatric endocrinology medical conference by attending in person. A virtual option is available for those unable to travel, however we recommend joining us on-site to fully engage in interactive discussions and face-to-face connections with the PEARL community.
PEARL has served as the pediatric endocrinology regional meeting of the Pacific Northwest for over two decades. This event includes two featured keynote speakers and 15- or 30-minute lectures from selected presenters covering interesting or complex cases and original research. Trainees are encouraged to attend and present.
Contact
Charlene Lai, M.D., Program Director
laic@ohsu.edu
Katherine Larowe, Program Coordinator
larowe@ohsu.edu
503-494-1927
After PEARL 2023, attendees will be able to describe up-to-date clinical recommendations regarding the medical management of:
- Pediatric carbohydrate metabolism disorders
- Gender dysphoria in children and adolescents
- Pediatric thyroid disorders
- Pediatric adrenal disorders
- Puberty disorders
Janet Y. Lee, M.D., M.P.H., M.A.S.
Dr. Janet Y. Lee is currently Assistant Professor of Pediatrics and of Medicine at the University of California, San Francisco (UCSF), in the Divisions of Pediatric Endocrinology and Endocrinology & Metabolism. She provides clinical care at UCSF Health and the San Francisco Veterans Affairs Health Care System (SFVAHCS), primarily in metabolic bone diseases, gender-affirming medical care, and differences in sex development, and her research program focuses on the skeletal effects of gender-affirming medical therapy in early pubertal transgender and gender diverse youth. She serves as the Assistant Medical Director of the UCSF Child and Adolescent Gender Center and Lead Endocrinologist of the Trans Health Clinic at the SFVAHCS.
Linda A. DiMeglio, M.D., M.P.H.
Dr. Linda A. DiMeglio is a Professor and the Chief of the Division of Pediatric Endocrinology and Diabetology in the Department of Pediatrics at Riley Hospital for Children in Indianapolis, Indiana. She is also the Indiana Clinical and Translational Research Institute (CTSI) Director of Career Development and co-chairs the CTSI Pediatric Project Development Team.
Dr. DiMeglio directs local and national research teams focused on preventing type 1 diabetes, preserving beta cell function, and improving metabolic control and quality of life for persons living with the disease. She is the Vice Chair for Type 1 Diabetes TrialNet and the co-PI of the newly funded DiabDocs K12 Physician Scientist Program. She is a member of the ISPAD Guidelines Editorial Board. She also is engaged in research in metabolic bone diseases.
In addition to 2 keynote speakers, PEARL content consists of 15 and 30 minute presentations by faculty, fellows and other clinicians. Those selected to present from outside of Portland will receive one night accommodations at the Kimpton RiverPlace hotel.
Interested presenters should send their preliminary title and objectives, as well as if they would like a 15 or 30 minute presentation slot, to Charlene Lai
Presentation spots are limited - apply soon!
Accreditation:
Oregon Health & Science University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit:
OHSU School of Medicine designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.